A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Clinical trial NCT02009449 · COMPLETED

Trial details

NCT number: NCT02009449
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Prostate Cancer Ovarian Cancer Renal Cell Carcinoma Colorectal Carcinoma Pancreatic Carcinoma Non-small Cell Lung Carcinoma Solid Tumors Breast Cancer

Start date: 2013-11-15
Primary completion: 2019-02-19
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.